To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Parkinson's Disease: Medical Treatments
Friday 7th March 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure (a) timely adjustments of medications and (b) access to treatments for people with Parkinson's.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Clinicians are responsible for making prescribing decisions for their patients, taking into account best prescribing practice and the local commissioning decisions of their respective integrated care boards. They are also expected to take account of appropriate national guidance on clinical and cost effectiveness, and are accountable for their prescribing decisions, both professionally and to their service commissioners.

Timely adjustment and optimisation of medicines are important to ensure patients are receiving the most clinically appropriate and effective treatment to support their health and wellbeing. It is also critical in underpinning the six rights of safe medicines management: the right person; right medicine; right route; right dose; right time; and right to decline.

The National Institute of Health and Care Excellence (NICE) is the independent body responsible for translating evidence into authoritative guidance for the health and care system on best practice. The NICE has produced guidance on the management of Parkinson’s disease, which includes recommendations on pharmacological management, including the timing of medicine administration. The NICE has also developed a Quality Standard for Parkinson’s disease that states that adults with Parkinson's disease who are in hospital, or a care home, should take levodopa within 30 minutes of their individually prescribed administration time. Clinicians are expected to take relevant national guidance fully into account when making clinical decisions regarding their patients, including the adjustment of medications.

The Department is aware of supply constraints with one supplier of amantadine 100 milligram capsules used in the management of Parkinson’s disease, however stocks remain available from alternative suppliers to cover demand. The Department has also been notified of a discontinuation of apomorphine (APO-go PFS) 50 milligram/10 millilitre pre-filled syringes from April 2025. Alternative formulations of apomorphine remain available for patients and management guidance has been issued to the National Health Service.


Written Question
Parkinson's Disease: Health Services
Wednesday 5th March 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that patients with Parkinson receive regular consultations.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

We have delivered an additional two million appointments, seven months ahead of schedule. This includes operations, consultations, diagnostic tests and treatments. These additional appointments have taken place across several specialities, including neurology.

We have launched a 10-Year Health Plan to reform the National Health Service. The plan will set out a bold agenda to deliver on the three big shifts needed to move healthcare from hospital to the community, analogue to digital and treatment to prevention. A central and core part of the 10-Year Health Plan will be our workforce and how we ensure we train and provide the staff, technology and infrastructure the NHS needs to care for patients across our communities.

There are several initiatives supporting service improvement and better care for patients with Parkinson’s disease in England, including the Getting It Right First Time (GIRFT) Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit and the Neurology Transformation Programme (NTP).

The GIRFT National Specialty Report made recommendations designed to improve services nationally and to support the NHS to deliver care more equitably across the country. The report highlighted differences in how services are delivered and provided the opportunity to share successful initiatives between trusts to improve patient services nationally. In addition, the NTP has developed a model of integrated care for neurology services to support integrated care boards to deliver the right service, at the right time for all neurology patients, including providing care closer to home.

Once diagnosed, and with a management strategy in place, most people with Parkinson’s can be cared for through routine access to primary and secondary care. NHS England commissions the specialised elements of Parkinson’s care that patients may receive from 27 neurology centres across England. Within specialised centres, neurological multidisciplinary teams ensure patients can access a range of health professionals, including Parkinson’s disease nurses, psychologists and allied health professionals such as dieticians and speech and language therapists, and that they can receive specialised treatment and support, according to their needs.


Written Question
Homelessness and Temporary Accommodation
Monday 3rd March 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Ministry of Housing, Communities and Local Government:

To ask the Secretary of State for Housing, Communities and Local Government, what steps her Department is taking to help reduce (a) homelessness and (b) the number of children in temporary accommodation.

Answered by Rushanara Ali - Parliamentary Under-Secretary (Housing, Communities and Local Government)

Homelessness levels are far too high. This can have a devastating impact on those affected. The Deputy Prime Minister is leading cross-government work to deliver the long-term solutions we need to get us back on track to ending all forms of homelessness. This includes chairing a dedicated Inter-Ministerial Group, bringing together ministers from across the key government departments with the greatest impact on homelessness to develop a long-term strategy, and an Expert Group bringing together representatives from across the homelessness and rough sleeping sector. We continue to engage with DEFRA on measures as part of the development of our long-term housing strategy. We are also delivering a number of lived experience forums to ensure that the voices of those with lived experience are reflected in the homelessness strategy.

We are already taking the first steps to get back on track to ending homelessness. As announced at the Budget, grant funding for homelessness services is increasing this year by £233 million compared to last year (2024/25). This increased spending will help to prevent rises in the number of families in temporary accommodation and help to prevent rough sleeping. This brings total funding to nearly £1 billion in 2025/26.

Further information on the allocations of homelessness grant funding in the 2025/26 financial year can be found in the following link: https://www.gov.uk/government/publications/homelessness-prevention-grant-allocations-2025-to-2026

The Government is also tackling the root causes of homelessness, including the delivery of the biggest increase in social and affordable housebuilding in a generation and building 1.5 million new homes over the next parliament. And the Renters’ Rights Bill will abolish Section 21 ‘no fault’ evictions, prevent private renters being exploited and discriminated against, and empower people to challenge unreasonable rent increases.


Written Question
Food Supply
Wednesday 5th February 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, what recent progress his Department has made on developing a food strategy.

Answered by Daniel Zeichner - Minister of State (Department for Environment, Food and Rural Affairs)

On December 10, the Secretary of State spoke to businesses and industry groups from across the food sector and confirmed that work is underway to develop an ambitious food strategy. In developing the strategy, we are establishing a new way of working with the sector, building on strong partnerships to create a strategy drawing on shared expertise and collective commitments, backed by a clear vision and framework for change from government. Work to develop this is ongoing.


Written Question
Diagnosis and Surgery: Yorkshire and the Humber
Monday 3rd February 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to paragraph 4.5 of the Autumn Budget 2024, how many new (a) surgical hubs and (b) diagnostic scanners will be located in Yorkshire.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Elective Reform Plan, published in January 2025, sets out the productivity and reform efforts needed to return to the 18-week Referral to Treatment constitutional standard by March 2029. The standard has not been met consistently since September 2015.

Surgical hubs offer productive solutions by focusing on providing high volume low complexity surgery, and will contribute to providing the surgical capacity needed to return to the constitutional standard. There are 112 elective surgical hubs operational across England as of December 2024. There are 14 surgical hubs already operational in the North East and Yorkshire region, and three more are planned to open. These three are:

- the Dewsbury and District Hospital Combined Elective Centre in Dewsbury;

- the St Luke's Hospital Day Case Unit in Bradford; and

- the Castle Hill Hospital Elective Hub in Cottingham.

The Department cannot yet confirm the location of all the new surgical hubs and diagnostic scanners from the capital investment announced in the Autumn Statement. NHS England is working with local National Health Service systems to identify the most appropriate locations for investments, including new surgical hubs and diagnostic scanners. Details will be set out at the earliest opportunity.

As detailed in the 2025/26 capital guidance, NHS England has provided systems with indicative allocations based on a combination of population-weighted shares and national and regional intelligence on where investment is needed and if it can be delivered within 2025/26. These allocations include funding for additional surgical hubs, diagnostic scanning capacity, urgent treatment centres co-located with emergency departments, and same day emergency care provision in those systems prioritised for these investments by national teams.


Written Question
Suicide
Tuesday 28th January 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Cabinet Office:

To ask the Minister for the Cabinet Office, what steps he is taking to help ensure that frontline public sector workers are sufficiently resourced to support the (a) implementation of suicide prevention training and (b) effective provision of support to people at risk of suicide.

Answered by Georgia Gould - Parliamentary Secretary (Cabinet Office)

I refer the Hon Member to the answer given by the Department of Health and Social Care on 16 January 2025, Official Report, PQ 24604


Written Question
Blood Cancer
Monday 27th January 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans to make an assessment of the potential merits of (a) introducing a proxy staging measure for non-stageable blood cancers and (b) applying a national target to (i) measure and (ii) support a reduction in levels of late diagnosis.

Answered by Andrew Gwynne

There are no current plans to introduce a specific proxy staging measure or a corresponding national target to support the earlier diagnosis of blood cancers.

It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancer, as early and quickly as possible, and to treat it faster, to improve outcomes. We will get the NHS diagnosing blood cancer earlier and treating it faster. We will start by delivering an extra 40,000 operations, scans, and appointments each week, as the first step to ensuring early diagnosis and faster treatment.

In addition to improving cancer waiting time performance, the NHS has implemented non-specific symptom pathways for patients who present with vague and non-site-specific symptoms, which do not clearly align to a tumour type. This includes blood cancer, which the national evaluation found was one of the most common cancers diagnosed via these pathways.

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including those with blood cancer and other cancers with lower survival rates. We are now in discussions about what form that plan should take, and what its relationship to the 10-Year Health Plan and the Government’s wider Health Mission should be and will provide updates in due course.


Written Question
Blood Cancer: Diagnosis
Monday 27th January 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to help mitigate the impact of (a) delayed diagnosis and (b) emergency presentation rates on people with blood cancer.

Answered by Andrew Gwynne

The Government has not taken a specific assessment on the potential impact of late diagnosis on outcomes for people with blood cancer. It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancer, as early and quickly as possible, and to treat it faster, to improve outcomes. We will start by delivering an extra 40,000 operations, scans, and appointments each week, as the first step to ensuring early diagnosis and faster treatment.

In addition to improving cancer waiting time performance, the NHS has implemented non-specific symptom pathways for patients who present with vague and non-site-specific symptoms, which do not clearly align to a tumour type. This includes blood cancer, which the national evaluation found was one of the most common cancers diagnosed via these pathways, therefore mitigating the impact of late diagnosis, and reducing emergency presentation.

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including those with blood cancer and other cancers with lower survival rates. We are now in discussions about what form that plan should take, and what its relationship to the 10-Year Health Plan and the Government’s wider Health Mission should be, and we will provide updates in due course.


Written Question
Blood Cancer: Diagnosis
Monday 27th January 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made on the potential impact of late diagnosis on outcomes for people with blood cancer.

Answered by Andrew Gwynne

The Government has not taken a specific assessment on the potential impact of late diagnosis on outcomes for people with blood cancer. It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancer, as early and quickly as possible, and to treat it faster, to improve outcomes. We will start by delivering an extra 40,000 operations, scans, and appointments each week, as the first step to ensuring early diagnosis and faster treatment.

In addition to improving cancer waiting time performance, the NHS has implemented non-specific symptom pathways for patients who present with vague and non-site-specific symptoms, which do not clearly align to a tumour type. This includes blood cancer, which the national evaluation found was one of the most common cancers diagnosed via these pathways, therefore mitigating the impact of late diagnosis, and reducing emergency presentation.

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including those with blood cancer and other cancers with lower survival rates. We are now in discussions about what form that plan should take, and what its relationship to the 10-Year Health Plan and the Government’s wider Health Mission should be, and we will provide updates in due course.


Written Question
BBC: Finance
Monday 27th January 2025

Asked by: Paul Davies (Labour - Colne Valley)

Question to the Department for Digital, Culture, Media & Sport:

To ask the Secretary of State for Culture, Media and Sport, what recent discussions she has had with the BBC on the financial pressures it faces.

Answered by Stephanie Peacock - Parliamentary Under Secretary of State (Department for Culture, Media and Sport)

The Secretary of State is a strong supporter of the BBC and, with Charter Review approaching, wants to ensure the long term financial sustainability of the corporation.

Ministers and officials in the Department for Culture, Media and Sport have regular discussions with the BBC, and the Secretary of State had her first formal meeting on the Charter Review process with the Director General in November 2024.

As part of the next Charter Review, discussions with the BBC will continue to focus on how to ensure the BBC thrives well into the next decade and beyond. This will include ongoing discussions on a range of important issues, including future funding models. Funding the BBC through general taxation is not being considered.